Europe Point of Care Diagnostics Market Trends, Size, Segment and Growth by Forecast to 2030 Market

business market insights

Right Now

Europe Point of Care Diagnostics Market Trends, Size, Segment and Growth by
Forecast to 2030

Market Overview and Dynamics

The Europe point of care (POC) diagnostics market is projected to grow significantly,
rising from US$ 8,948.81 million in 2021 to US$ 20,207.60 million by 2028,
at a compound annual growth rate (CAGR) of 12.3% during the forecast
period. This growth is driven by several key factors that are reshaping the
landscape of diagnostic healthcare in the region.

A major contributor to this expansion is the increasing
adoption of home-based POC devices, fueled by rising awareness and consumer
demand for convenient, rapid diagnostic solutions. These devices enable
patients to perform critical tests in the comfort of their homes, eliminating
the need for frequent clinic visits. Clinicians are also recognizing POC
testing as essential for early detection of life-threatening conditions,
thanks to its ability to deliver real-time results.

📚Download Full PDF Sample Copy of Market
Report @https://www.businessmarketinsights.com/sample/TIPRE00023727

Moreover, the integration of smartphones with diagnostic
technologies is accelerating market adoption. Consumers increasingly use
smartphones equipped with health-monitoring apps for imaging, sensing, and
diagnostics. Traditional home-use devices like glucose meters are now being
repurposed for a broader range of clinical applications, including immunoassays,
molecular diagnostics, and enzymatic assays, highlighting the market’s
innovation potential.

The aging population across Europe is another pivotal
driver. As the geriatric demographic grows, so does the demand for regular
health checkups and diagnostics. Common conditions among older adults—such as
cardiovascular diseases, diabetes, bone and joint disorders, and various
cancers—necessitate frequent and accessible testing. This demographic
shift is significantly boosting the demand for POC diagnostics across the
region.

Overall, the Europe POC diagnostics market is on a strong
upward trajectory, supported by technological advancements, demographic
changes, and shifting healthcare preferences that emphasize decentralized
and patient-centric care.

Market Introduction

Europe is the second-largest market for point-of-care
diagnostics, with key contributions from the UK, Germany, France, Italy, Spain,
and other European countries. The market's growth is driven by increasing
demand for advanced diagnostic solutions, a rising prevalence of infectious and
chronic diseases, and growing investments in research and development.
Additionally, the presence of a well-established manufacturing infrastructure
for diagnostic products supports the expansion of the point-of-care diagnostics
market in the region.

Germany currently leads the market, supported by government
initiatives aimed at improving healthcare outcomes. For example, in November
2017, Lilly Germany launched the Diabetes Work initiative to raise awareness
about diabetes—an effort expected to increase the adoption of diagnostic kits.
Furthermore, in September 2018, the German government approved the marketing
and sale of over-the-counter (OTC) HIV home testing kits, further facilitating
market growth.

The COVID-19 pandemic significantly impacted Europe,
particularly in countries like France, Spain, Italy, Germany, and the UK, which
reported high infection and mortality rates. The World Health Organization
(WHO) declared COVID-19 a Public Health Emergency of International Concern
under the International Health Regulations. The surge in infections accelerated
the demand for rapid and advanced diagnostic solutions, creating favorable
conditions for the widespread adoption of point-of-care diagnostic kits across
the region.

Despite the challenges posed by the pandemic, increased
investments and proactive measures by industry players have continued to propel
market growth. In 2020, the European Medicines Agency (EMA) approved 97
medicines for marketing authorization, including 39 novel drugs. Companies also
launched innovative COVID-19 testing solutions to meet demand. For instance,
Eurofins introduced COVID-19 PCR tests with at-home self-sampling in October
2020. Around the same time, Siemens Healthineers launched the CLINITEST rapid
antigen test, which delivers results in 15 minutes. In April 2021, QIAGEN
announced the launch of its Prep&Amp technology to accelerate COVID-19
testing. The kit received CE approval for distribution in Europe and was
submitted for Emergency Use Authorization (EUA) in the U.S.

Europe Point of Care Diagnostics Strategic Insights

Strategic insights for the Europe Point of Care Diagnostics
provides data-driven analysis of the industry landscape, including current
trends, key players, and regional nuances. These insights offer actionable
recommendations, enabling readers to differentiate themselves from competitors
by identifying untapped segments or developing unique value propositions.
Leveraging data analytics, these insights help industry players anticipate the
market shifts, whether investors, manufacturers, or other stakeholders. A
future-oriented perspective is essential, helping stakeholders anticipate
market shifts and position themselves for long-term success in this dynamic
region. Ultimately, effective strategic insights empower readers to make
informed decisions that drive profitability and achieve their business
objectives within the market.

Market leaders and key company profiles

 Abbott

 BD

 bioMerieux SA

 BIO-RAD
LABORATORIES INC.

 Danaher

 F. HOFFMANN-LA ROCHE LTD.

 Johnson and Johnson
Services, Inc.

 Nova Biomedical

 Polymer Technology
Systems, Inc. (PTS)

 Siemens AG

Europe Point of Care Diagnostics Regional Insights

The geographic scope of the Europe Point of Care Diagnostics
refers to the specific areas in which a business operates and competes.
Understanding local distinctions, such as diverse consumer preferences (e.g.,
demand for specific plug types or battery backup durations), varying economic
conditions, and regulatory environments, is crucial for tailoring strategies to
specific markets. Businesses can expand their reach by identifying underserved
areas or adapting their offerings to meet local demands. A clear market focus
allows for more effective resource allocation, targeted marketing campaigns,
and better positioning against local competitors, ultimately driving growth in
those targeted areas.

Key Market Segments

In 2020, glucose monitoring products dominated the
Europe point-of-care diagnostics market by product type. Based on prescription
mode, the prescription-based testing segment held the largest market
share. Regarding end users, professional diagnostic centers accounted
for the highest share of the market.

Major Sources and Companies Featured

Key primary and secondary sources used in the preparation of
this report include company websites, annual and financial reports, government
publications, and statistical databases. Leading companies profiled in the
report include: